Brought to you by
ECR 2019 / C-1666
Cholecystectomy or percutaneous cholecystostomy as treatment for acute acalculous cholecystitis: 12 years of experience
Congress: ECR 2019
Poster No.: C-1666
Type: Scientific Exhibit
Keywords: Biliary Tract / Gallbladder, Interventional non-vascular, Emergency, Percutaneous, Ultrasound, Catheters, Drainage, Surgery, Infection, Inflammation, Outcomes
Authors: I. Vicente Zapata, D. Flores Funes, A. Blanco Barrio, J. F. Sánchez Melgarejo; Murcia/ES
DOI:10.26044/ecr2019/C-1666

Aims and objectives

Acute Acalculous cholecystitis is rare, accounting for less than 10% of acute cholecystitis cases. It frequently develops in elderly patients and also as a complication in critically ill patients being treated for other medical conditions, systemic diseases, leukemia, acquired inmune deficiency syndrome, etc (Fig. 1).

 

Literature about the best treatment option for acute acalculous cholecystitis (ACC) has been recently examined in several papers. Is it cholecistectomy or percutaneous cholecystostomy? All patients should be given broad-spectrum antibiotics once cholecystitis has been confirmed (with a grade of recommendation 1B). Due to the high surgical risk of these patients, it is generally accepted that percutaneous cholecystostomy is the best treatment for AAC [1-3]. This could also be a definitive treatment, not just a bridge strategy, with no need for posterior elective cholecystectomy.

As no randomized controlled trials are available on this issue, the grade of recommendation for this procedure is 2C (Fig. 2).

 

The purpose of our study is to compare a series of cases of AAC over a 12-year period, those treated with surgery versus conservative treatment and analyze the outcomes and efficacy (Fig. 3).

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more